Ultimaster TANSEI Stent in Complex Coronary Lesions: The EPIC08 TANSEI COMPLEX Study.

Interv Cardiol · 2026 · PMC13084724 · PMID 42003940

Europe PMC DOI

hedged sentence

0.1020

closest p · 2.0× alpha

0.1020

boldest claim

The sentences

a nonsignificant trendp=0.102not close (p > 0.1)

Compared with non-CTO patients, there was a nonsignificant trend toward higher event rates in the CTO group, with PoCE: RR 2.15 (95% CI [0.96–4.83]; p=0.102) and stent thrombosis: RR 4.57 (95% CI [0.94–22.29]; p=0.074).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.